Drugs / Cord Blood Cell
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT01471613 | Sep 2011 → Dec 2013 | spinal cord injury | China Spinal Cord Injury Network | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Cord Blood Cell | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01471613 ↗ |
| Modality | Cell therapy | “Cord blood mononuclear cell, 6.4 million viable cells, are transplanted into spinal cord at upper and lower edges of the injured site” NCT01471613 ↗ |
| Route | Other | “transplanted into spinal cord at upper and lower edges of the injured site” NCT01471613 ↗ |